The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity

• Chrysiis Michaloglou,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Waltraut Lehmann,

  Current address: University of Freiburg, Freiburg, Germany

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Typhaine Martin,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Clara Delaunay,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Andreas Hueber,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Louise Barys,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Honglin Niu,

  Affiliation Novartis Institutes for BioMedical Research, Center for Proteomic Chemistry, Cambridge, Massachusetts, United States of America

  ⨯
• Eric Billy,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Markus Wartmann,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Moriko Ito,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• Christopher J. Wilson,

  Affiliation Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Cambridge, Massachusetts, United States of America

  ⨯
• Mary Ellen Digan,

  Affiliation Novartis Institutes for BioMedical Research, Center for Proteomic Chemistry, Cambridge, Massachusetts, United States of America

  ⨯
• Andreas Bauer,

  Affiliation Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Basel, Switzerland

  ⨯
• Hans Voshol,

  Affiliation Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Basel, Switzerland

  ⨯
• Gerhard Christofori,

  Affiliation Department of Biomedicine, Institute of Biochemistry and Genetics, University of Basel, Basel, Switzerland

  ⨯
• William R. Sellers,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Cambridge, Massachusetts, United States of America

  ⨯
• Francesco Hofmann,

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
•  [ ... ],
• Tobias Schmelzle

  * E-mail: tobias.schmelzle@novartis.com

  Affiliation Novartis Institutes for BioMedical Research, Disease Area Oncology, Basel, Switzerland

  ⨯
• [ view all ]
• [ view less ]